Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest Content
Current issue
Archive
For authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest Content
Current issue
Archive
For authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Dual antiplatelet therapy
Email alerts
Dual antiplatelet therapy
Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms
Edgar A
Samaniego
,
Emilee
Gibson
,
Daichi
Nakagawa
,
Santiago
Ortega-Gutierrez
,
Mario
Zanaty
,
Jorge A
Roa
,
Pascal
Jabbour
,
David M
Hasan
Stroke and Vascular Neurology
Mar 2019,
4
(1)
36-42;
DOI:
10.1136/svn-2018-000192
Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial
Runqi
Wangqin
,
Xianwei
Wang
,
Yilong
Wang
,
Ying
Xian
,
Xingquan
Zhao
,
Liping
Liu
,
Hao
Li
,
Xia
Meng
,
Yongjun
Wang
Stroke and Vascular Neurology
Dec 2017,
2
(4)
176-183;
DOI:
10.1136/svn-2017-000088
Special collections
Editor's choice
(3)
Guidelines, Recommendations and Consensus Statements
Open access
(109)
